← SynDRA
ACETOHEXAMIDE
SynDRA canonical compound SYN0011820 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Primary target(s) | ABCC8 | KCNJ1 | KCNJ10 | KCNJ11 |
| Mechanism of action | ATP channel blocker |
| Indication | diabetes mellitus |
| Disease area | endocrinology |
All known targets
- ABCC8
- KCNJ11
- KCNJ1
- KCNJ10
Mechanisms of action (all sources)
- KCNJ11 BLOCKER
- Sulfonylurea receptor 1, Kir6.2 blocker
- ABCC8 BLOCKER
- ATP channel blocker
- ABCC8 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- LMNA
- NPY1R
- NFE2L2
- MLNR
- MC4R
- MC3R
- MAOA
- KCNH2
- NR1I2
- KAT2A
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- NR1H4
- NR3C1
- HRH1
- SLC29A1
- THRB
- TDP1
- TBXA2R
- SLC6A4
- SLC6A3
- SLC6A2
- SAMHD1
- OPRD1
- PTGS2
- PGR
- PDE4D
- PDE3A
- OPRM1
- OPRK1
- HRH2
- HDAC6
- ADORA2A
- AGTR1
- BLM
- BDKRB2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- DYMELOR
- dymelor
- acetohexamid
- Acetohexamida
- 33006
- NSC-759128
- Dimelor
- Dymelor
- Acetohexamid
- Acetohexamidum
- Dimelin
- Gamadiabet
- Hypoglicil
- Metaglucina
- Minoral
- Ordimel
- Tsiklamid
- Acetohexamide Lilly Brand
- Acetohexamide Salvat Brand
- Lilly Brand of Acetohexamide
- Ord imel
- Salvat Brand of Acetohexamide
- U-14812
- A-178
- Acetohexamida [INN-Spanish]
- Acetohexamidum [INN-Latin]
- Dimelin (antidiabetic)
- Dymelor (TN)
- Acetohexamide (JP15/USP/INN)
- Acetohexamide [USAN:INN:BAN:JAN]
- N-(p-Acetylbenzenesulfonyl)-N'-cyclohexylurea
- N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea
- 1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea
- 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea
- 1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea
- 3-cyclohexyl-1-(p-acetylphenylsulfonyl)urea
- 4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide
Look up ACETOHEXAMIDE in the interactive SynDRA portal →